Those are not macro-scale arguments, and both have strong counter-arguments: Pharma can still make money manufacturing, distributing, and selling, and it does f

Those are not macro-scale arguments, and both have strong counter-arguments: Pharma can still make money manufacturing, distributing, and selling, and it does for out-of-patent products. Their patented products are often born in government and university research labs, and are privatized in what amounts to rent-seeking based on a public good. Anyone who has written books about specific kinds of software development knows that business is perhaps 10% as big as it used to be because manuals and experiential knowledge are freely available. Things change. So should patent and copyright protection. See you at the local stage production of GoT.